CAR-T therapy – Discover Pharma

Welcome to Discover Pharma! Today is : November 1, 2026

CAR-T therapy

Advanced Therapies,Central Nervous System,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Laverock Therapeutics expands into in vivo CAR-T and genetic medicine
Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

September 30, 2026
Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Australian Phase 1 trial begins for CAR-T therapy targeting solid tumours
A Phase 1/1b clinical trial has begun in Australia to [...]

July 10, 2026
Advanced Therapies,Drug Discovery & Development
Circio and GenAssist partner on next-generation gene therapies for muscle diseases
Circio and GenAssist have announced a research collaboration aimed at [...]

June 6, 2026
Advanced Therapies,Clinical & Regulatory,Therapeutic Areas
Novotech report explores how in-vivo CAR-T could transform cell therapy access and costs
A new whitepaper from Novotech has outlined how in-vivo CAR-T [...]

May 5, 2026
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Galapagos CAR-T therapy shows strong results in relapsed indolent NHL
Galapagos has announced promising results from Cohort 3 of its [...]

May 5, 2026
Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas
Galapagos taps CELLforCURE by SEQENS to manufacture CAR-T therapy in France
CELLforCURE by SEQENS has partnered with Galapagos to manufacture GLPG5101, [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK